Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Leukemia|April 13, 2022
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent yearsAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Annals of Hematology|January 20, 2017
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trialLaura Magnano, Silvia Montoto, Eva González-Barca, et al.
British Journal of Haematology|October 11, 2021
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphomaIvan Dlouhy, Kennosuke Karube, Anna Enjuanes, et al.
Leukemia & Lymphoma|December 6, 2021
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad S Halwani, Carlos Panizo, Iris Isufi, et al.
British Journal of Haematology|December 15, 2018
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO groupAlba M Redondo, David Valcárcel, Ana P González-Rodríguez, et al.
Leukemia & Lymphoma|August 30, 2021
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up resultsArmando López-Guillermo, Miguel Ángel Canales, Ivan Dlouhy, et al.
Cancer Discovery|May 30, 2023
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical DevelopmentMichael J Dickinson, Pere Barba, Ulrich Jäger, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 27, 2024
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell featuresBelén Sierro-Martínez, Virginia Escamilla-Gómez, Laura Pérez-Ortega, et al.
Frontiers in Immunology|May 1, 2023
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignanciesClara Beatriz García-Calderón, Belén Sierro-Martínez, Estefanía García-Guerrero, et al.
Transplantation and Cellular Therapy|July 28, 2024
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMORebeca Bailén, Gloria Iacoboni, Javier Delgado, et al.
Pageof 11